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Functional Characterization and Expression Analysis
of the Proteinase-Activated Receptor-2 in Human
Cutaneous Mast Cells
Corinna Moormann1,5, Metin Artuc2,5, Elena Pohl3, Georg Varga1, Jo¨rg Buddenkotte1, Nathalie Vergnolle4,
Randolf Brehler1, Beate M. Henz2, Stefan W. Schneider1, Thomas A. Luger1 and Martin Steinhoff1
Proteinase-activated receptor-2 (PAR2) belongs to a new G protein-coupled receptor subfamily activated by
serine proteinases. PAR2 has been demonstrated to play a role during inflammation and immune response in
different tissues including the skin. We examined whether PAR2 is functionally expressed by cutaneous human
primary skin mast cells (HPMC) and the human mast cell line 1 (HMC-1). Reverse transcription-polymerase
chain reaction and FACS analysis show expression of PAR2 both at the RNA and protein level. HPMCs and HMC-1
also express PAR1, PAR3, and PAR4. Ca-mobilization studies demonstrate functional PAR2 expressed by human
skin mast cells, as shown by natural and synthetic PAR2 agonists. PAR2 agonists induced histamine release from
HPMC indicating a role of PAR2 in regulating inflammatory and immune responses by skin mast cells. Double-
immunofluorescence staining reveals colocalization of PAR2 with tryptase in the majority of human skin mast
cells. In conclusion, trypsin and tryptase as well as specific agonists for PAR2 were able to induce Ca
2þ
mobilization in HPMCs, and agonists of PAR2 induce the release of histamine from these cells. Thus, PAR2 may
be an important regulator of skin mast cell function during cutaneous inflammation and hypersensitivity.
Journal of Investigative Dermatology (2006) 126, 746–755. doi:10.1038/sj.jid.5700169; published online 9 February 2006
INTRODUCTION
Proteinase-activated receptor-2 (PAR2) belongs to a new
subfamily of G-protein-coupled receptors with seven trans-
membrane domains. At present, four PARs have been
identified by molecular cloning (Coughlin, 2000; Macfarlane
et al., 2001; Ossovskaya and Bunnett, 2004). PAR2 is exp-
ressed in various tissues and is also found in numerous cells
involved in inflammatory and immune responses (reviewed
in Steinhoff et al., 2005). On the other hand, some cells, for
example, human platelets, do not express PAR2 (Blackhart
et al., 1996; Hwa et al., 1996; Steinhoff et al., 2005).
A variety of serine proteases (eg trypsin and tryptase) as
well as microbiological agents (bacteria, house-dust mite
allergens) are capable of activating PAR2 (reviewed in
Steinhoff et al., 2005).
In the skin, PAR2 is expressed by keratinocytes, activated
endothelial cells, and sensory nerves (Hou et al., 1998;
Steinhoff et al., 1999; Shpacovitch et al., 2002). PAR2
upregulates cytokine release and cell adhesion molecule
expression during experimentally induced contact dermatitis
via nitric oxide (Seeliger et al., 2003). It has also been shown
that PAR2 can regulate cutaneous inflammation via a
neurogenic mechanism (Steinhoff et al., 2000). Together,
these results indicate that PAR2 is an important regulator of
immune and inflammatory responses in the skin (Steinhoff
et al., 2005).
Human mast cells produce a broad array of proinflamma-
tory mediators including preformed mediators such as
histamine, proteoglycans, and neutral proteinases like tryp-
tase and chymase. Many of these mediators are stored in
intracellular secretory granules and released by triggered
exocytosis after mast cell activation. Mast cells have been
implicated in many skin diseases including inflammation,
hypersensitivity, and tissue repair (Benoist and Mathis, 2002).
Via histamine release, mast cells communicate with sensory
nerves and blood vessels, thereby regulating neurogenic
inflammation and pruritus (Steinhoff et al., 2003).
Various in vitro and in vivo investigations of different
species suggest a functional role of PAR2 on mast cells in
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certain tissues. So far, PAR2 expression has been demon-
strated on human mast cell line 1 (HMC-1) and in mast cells
from various normal tissues (He et al., 2005; Steinhoff et al.,
2005). In other tissues, however, evidence for the expression
and/or function of PAR2 in mast cells was lacking such as
airways (He et al., 2004a, b).
Histamine is rapidly released upon mast cells stimulation
and is a powerful mediator on blood vessels causing smooth
muscle contraction, vasodilatation, and plasma extravasation
from capillaries. Histamine mediates itch responses espe-
cially at the beginning of an inflammatory response by
activating histamine receptors (HR) on cutaneous sensory
nerves (Xie and He, 2005).
Mast cell tryptase is one of the crucial molecules released
by mast cells during inflammation, allergic reactions, and
tissue repair (Fiorucci and Ascoli, 2004). It is able to cleave
many extracellular substrates involved in inflammation and
tissue repair (Tam and Caughey, 1990; Lohi et al., 1992;
Walls et al., 1992). Tryptase activates PAR2 on several cells
indicating that at least a part of the tryptase-mediated effects
in the skin may be induced via PAR2 activation (Corvera
et al., 1997; Steinhoff et al., 1999, 2000; Shpacovitch et al.,
2002).
The hypothesis that tryptase may effect mast cell function
is intriguing because it would mean that proteases may be
potential modulators of skin mast cell function via PAR2. This
may have implications for our understanding of cutaneous
mast cells function under physiological and pathophysio-
logical conditions and therapeutic interventions.
As tryptase is an important regulator of cutaneous
inflammation and immunity, we analyzed whether skin-
derived human mast cells may express functional PAR2 and
whether mast cell tryptase is capable of stimulating mediator
release from these cells via PAR2. Therefore, the aim of this
study was to (1) detect the expression of PAR2 on human
primary skin mast cells (HPMC) in human skin, both
at the RNA- and protein level, (2) investigate whether
PAR2 is functional on cutaneous mast cells using specific
PAR2 agonists, trypsin and tryptase, (3) determine
whether PAR2 agonists induce histamine release from skin
HPMCs.
RESULTS
Detection of PAR1-4 mRNA by reverse transcription-polymerase
chain reaction analysis
To detect expression of PAR1–4 mRNA in freshly isolated skin-
derived HPMCs and the mast cell line HMC-I, RNA was
extracted, reverse transcribed, and amplified with specific
primers for PAR1 to PAR4 (Figure 1). In both cell types (panel
a: HMC-1 and panel b: HPMCs, lanes 1–4), reverse
transcription-polymerase chain reaction (RT-PCR) of mRNA
revealed specific products in the expected range (PAR1:
708 bp, PAR2: 436 bp, PAR3: 382 bp, and PAR4: 392 bp).
PAR2 was identical to the bands received from keratinocytes
and endothelial cells (Steinhoff et al., 1999; Shpacovitch
et al., 2002). Each sample was analyzed at least twice. The
presented experiment is representative of four independent
experiments, with similar results. The PAR2 PCR products of
the cell line HMC-1 were sequenced and found to
correspond to published sequences (data not shown).
Flow cytometric analysis of PAR2 in human dermal mast cells
and HMC-1 cells
PAR2 was also detected in both types of cells at the protein
level by flow cytometry (Figure 2). Each figure represents an
analysis of 10,000 events. The well-established PAR2-B5
antibody was used for staining of PAR2, both at the cell
surface and intracellularly. PAR2 staining was correlated with
the secondary antibody (FITC-conjugated anti-rabbit IgG)
signal as a negative control. As shown in panel a, HPMCs
show about 47% cell surface staining for PAR2 and
approximately 99% intracellular staining for PAR2. In
contrast, secondary antibody staining demonstrated only
0.59 and 0.27% positive cells demonstrating specificity of
this staining. Similar results were observed in HMC-1 cells
(Figure 2b). Although cell surface staining for PAR2 was about
57% in HMC-1 cells, intracellular levels for PAR2 were
approximately 99% in these cells. Again, secondary antibody
staining was in the background range (Figure 2b).
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Figure 1. Detection of PAR1-4 mRNA by RT-PCR analysis. RNA was
extracted, reverse transcribed, and amplified with specific primers for PAR1–4.
Products were separated on a 2% (w/v) agarose gel, stained with ethidium
bromide, and photographed. PCR products for PAR1–4 were amplified from
the (a) mast cell line HMC-1 (lanes 1–4) and (b) human primary mast cells
(lanes 1–4). Lane 1: 100 bp DNA ladder; lane 2: PAR1 (708 bp), lane 3: PAR2
(436 bp), lane 4: PAR3 (382 bp), lane 5: PAR4 (392 bp).
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Immunfluorescence and double immunofluorescence for PAR2
and tryptase in human skin tissues
Both PAR2 agonists and tryptase exert similar functions in
human skin under physiological and pathophysiological
conditions playing a role during inflammation and hypersen-
sitivity. For example, PAR2 agonists stimulate secretion of
cytokines and cell adhesion molecules (Wakita et al., 1997,
Shpacovitch et al., 2002). Furthermore, PAR2 agonists induce
the upregulation of NF-kB in keratinocytes and dermal
endothelial cells (Shpacovitch et al., 2002; Buddenkotte
et al., 2005), a crucial transcription factor during inflamm-
ation and the immune response. Similarly, tryptase regulates
cytokines, cell adhesion molecules, and extracellular matrix
proteins in the skin and thus appears to play a pivotal role
during cutaneous inflammation, allergic responses, extracel-
lular matrix regulation, and tumor growth (Payne and Kam,
2004). Therefore, we determined whether the endogenous
activator of PAR2, tryptase, colocalizes with PAR2 in human
skin mast cells.
PAR2 immunoreactivity was localized in dermal mast cells
within human skin (Figure 3a). Interestingly, some (arrow-
heads) but not all mast cells stained for PAR2, which confirms
our FACS data for cell surface staining. Intense immuno-
reactivity for PAR2 (green) was observed in several dermal
mast cells, which also displayed immunoreactivity for
tryptase (red), as shown by double immunofluorescence
(arrowheads). Thus, PAR2 colocalizes with mast cell tryptase
in several human dermal mast cells in close proximity to
dermal blood vessels (arrows). Control staining for PAR2
preabsorption experiments (Steinhoff et al., 1999) did not
exhibit immunoreactivity in skin cells verifying specificity for
PAR2 in human skin mast cells (Figure 3b).
Effects of PAR2 agonists on [Ca
2þ ]I in human primary skin mast
cells
We have shown that both HPMCs and HMC-1 cells express
PAR2 mRNA and protein at similar levels. To determine the
role of PAR2 in primary human skin mast cells, we performed
functional studies in PAR2 activation merely in HPMCs. We
measured agonist-induced Ca2þ mobilization in HPMCs to
confirm expression of functional PAR2. Trypsin (0.1 mM)
caused a rapid increase in intracellular Ca2þ (Figure 4), with
a maximum at 3–4 seconds. PAR2 activation with activating
peptide (AP) for PAR2 (10 mM) and trypsin (0.1mM), as shown
in Figure 5 (panels a and b), demonstrated a transient increase
of intracellular Ca2þ characteristic of PAR2. Stimulation by
the control reverse-sequence peptide (10 mM) that cannot
activate PAR2 did not induce a Ca
2þ response (Figure 5,
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Figure 2. Flow cytometric analysis of human skin mast cells and HMC-1 cells for PAR2. FACS analysis shows PAR2 expression in (a) HPMCs and (b) HMC-1
cells. PAR2-B5 antibody was used for intracellular and extracellular staining of PAR2 (red continuous line). The black continuous line shows PAR2 staining with
the secondary antibody (FITC-conjugated anti-rabbit IgG), which served as a negative control. Three independent experiments were performed.
ba
Figure 3. Immunohistochemical localization of PAR2 and tryptase in human
skin mast cells. (a) Immunoreactivity for PAR2 (green) was observed in dermal
mast cells, which also displayed immunoreactivity for tryptase (red), as shown
by double immunofluorescence (arrowheads). PAR2-positive mast cells were
found in close anatomical association with PAR2-positive dermal endothelial
cells (arrows). (b) Control staining for PAR2 by preabsorption experiments did
not exhibit immunoreactivity in skin cells verifying specificity for PAR2 in
human skin mast cells.
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panel c), demonstrating specificity. Viability was verified by
subsequent application of trypsin (0.1mM) in identical cells,
showing rapid increase of intracellular Ca2þ concentration
[Ca2þ ]I. Thus, PAR2 agonists induce [Ca
2þ ]I mobilization
specifically and effectively in HPMCs. Similar results were
observed using HMC-1, indicating that PAR2 (data not
shown) is expressed both by primary skin mast cells and
the HMC-I mast cell line and is functional in these cells. To
determine whether tryptase activates HPMCs expressing
PAR2, we assessed the effects of tryptase on Ca
2þ mobiliza-
tion. Indeed, b-tryptase enhanced [Ca2þ ]I mobilization from
intracellular stores in primary skin mast cells (Figure 6).
Histamine release after activation by PAR2 agonists
Histamine release was measured in dermal mast cells from
three separate preparations. Stimulation of HPMCs with anti-
IgE led to a 23% increase in the release of total histamine.
This effect could be further enhanced (up to 34%) when
HPMCs were pretreated with PAR2-AP (10
4
M). When
HPMCs were stimulated with the activating PAR2-AP
(104 M) alone, a 9.5% increase in the release of total
histamine was observed. Non-activating PAR2-RP (10
4
M)
had no effect on histamine release. HPMCs responded to
PAR2-AP within 15 minutes. This time course is comparable
to that of activation by anti-IgE. Using highly purified (up to
70%) instead of only moderately purified mast cells, a
comparable level of histamine release was observed
(Figure 7).
DISCUSSION
A considerable number of reports suggest a crucial role of
PAR2 in cutaneous inflammation and hypersensitivity, mainly
by releasing neuropeptides and cytokines from nerves and
immunocompetent cells. The aim of this study was to
determine the functional expression of PAR2 in primary
human skin mast cells. Our results indicate that PAR2 is
expressed by HPMCs of normal human skin as well as by
HMC-1 cells. This was confirmed at the protein level using
FACS analysis and immunofluorescence. Ca-mobilization
studies reveal PAR2 to be functional in HPMCs using various
PAR2-agonists. Finally, PAR2 agonists stimulate histamine
release from HPMCs. Together, the activation of skin mast
cells may modulate inflammatory and immune responses in
human skin, thereby contributing to skin diseases in which
mast cells are involved.
Verification of functional PAR2 in HPMCs and human skin
We detected PAR2 mRNA in HPMCs and HMC-1 cells in the
expected molecular range by RT-PCR. Moreover, PAR1,
PAR3, and PAR4 expression was also found in these cells. The
localization of PAR2 in human mast cells was first reported by
D’Andrea et al. (2000). As shown by immunohistochemistry,
PAR2 was not only localized on the cell membrane of mast
cells, but also on the membrane of intracellular tryptase-
positive granules (D’Andrea et al., 2000).
We used two methods to detect PAR2 in HPMCs of human
skin. We localized immunoreactive PAR2 in approximately
50% of skin dermal mast cells using antibodies to distinct
epitopes. The same results were obtained with each antibody.
Preabsorption with the peptide antigen abolished the signal,
which confirms specificity. These results demonstrate that
PAR2 protein is localized in human skin mast cells, notably
around blood vessels. Second, we detected PAR2 protein in
cultured HPMCs by FACS analysis, which confirms results
received by RT-PCR and immunofluorescence in human skin.
As receptor expression and immunostaining does not
necessarily include biological function, we obtained evi-
dence for the expression of functional PAR2 on skin mast cells
by examining the effects of trypsin, tryptase, and AP for PAR2
on [Ca2þ ]I. Our results show that trypsin and tryptase as
well as specific AP for PAR2 were able to induce Ca
2þ
mobilization in HPMCs, indicating that functional PAR2 is
expressed by primary skin mast cells. In support of our results
from human tissue, He et al. (2002) recently described PAR2-
induced Ca2þ -mobilization on cultured primary human
colon mast cells. However, He et al. (2002) were unable to
find functional PAR2 on human airway tissue mast cells,
suggesting specificity for PAR2 function in various human
tissues (He et al., 2004a, b).
PAR2-induced histamine release in human skin mast cells
Histamine is an important mediator during cutaneous
inflammation and hypersensitivity. Our data indicate that
PAR2 is capable of stimulating the release of histamine from
human breast mast cells. This is in agreement with other
papers that demonstrated that PAR2 agonists induce hista-
mine release from human colon mast cells and human
foreskin mast cells (He et al., 2004a, b, 2005). Thus, PAR2 is a
potent stimulus for human skin mast cells. It is, however, still
unsolved which of the vascular responses are induced
directly by histamine or indirectly by PAR2. This is currently
under investigation.
Recently, He et al. (2005) described PAR2-induced release
of histamine and tryptase from human tonsil and foreskin
mast cells. Interestingly, trypsin as well as PAR2 agonists
stimulated a dose-dependent release of histamine but not of
0.000 second 1.625 seconds 3.250 seconds
8.125 seconds6.500 seconds4.875 seconds
10 m
Figure 4. Effects of trypsin on [Ca2þ ]I in human primary mast cells. HPMCs
were cultured and treated as described in Materials and methods. Stimulation
with trypsin (0.1 mM) leads to a rapid increase of intracellular Ca2þ in HPMCs,
with a maximum at 3–4 seconds, as detected by single-cell Ca2þ -mobilization
studies.
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tryptase in human foreskin mast cells. In contrast, anti-IgE and
CI (calcium ionophore) induced a marked increase of
histamine and tryptase release. The authors could demon-
strate that these compounds stimulated the release of both
histamine and tryptase in tonsil mast cells. These results
suggest a tissue-specific release of inflammatory mediators
such as tryptase. This is in agreement with our findings in
which we could show that AP for PAR2 stimulated the release
of histamine but not of tryptase (data not shown) from skin
breast mast cells. Moreover, our data indicate that tryptase is
capable of activating intracellular Ca-stores via PAR2
stimulation on skin mast cells.
Potential role of PAR2 in skin mast cell biology and
pathophysiology
PAR2 may participate in inflammation and cutaneous
hypersensitivity because PAR2 agonists stimulate the produc-
tion of histamine from cutaneous mast cells. Thus, PAR2 may
be involved in cutaneous neurogenic inflammatory responses
not only by inducing neuropeptide release from primary
a b
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154 seconds
178 seconds
177.7 seconds39.1 seconds0 second
195.6 seconds Trypsin 197.2 seconds 202.1 seconds
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10 m
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c
Figure 5. Long-term effects of AP, trypsin, and RP for PAR2-induced [Ca
2þ ]I mobilization in human primary mast cells. HPMCs were cultured and treated as
described in Materials and methods. (a and b) Demonstrate kinetics of PAR2-induced Ca
2þ mobilization by PAR2-AP (10 mM) and trypsin (0.1 mM). As shown in
(c), stimulation with 10 mM of RP for PAR2 did not induce [Ca
2þ ]I in HPMCs. Subsequent addition of trypsin after 3 minutes leads to a rapid increase of [Ca
2þ ]I in
the corresponding cells.
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afferent neurons (Steinhoff et al., 2000), but also directly by
stimulating histamine release from skin mast cells. Accord-
ingly, PAR2 may mediate pruritic effects in the skin not only
by acting directly on sensory ‘‘itch’’ fibers (Steinhoff et al.,
2003) but also via histamine binding to HRs on sensory
nerves (Figure 8). The biological relevance of PAR2 in human
skin physiology and pathophysiological conditions is, how-
ever, not clear as of yet and has to await further clarification.
Histamine represents an important molecule in the
‘‘neuro-immuno’’ communication network between sensory
nerves and mast cells (Steinhoff et al., 2003). Histamine, as a
proinflammatory, mediator is rapidly released from mast cells
upon degranulation. In human skin, histamine mediates
vasodilatation, plasma extravasation, and pruritus by activat-
ing HRs. To date, four HRs H1–4R are described which belong
to the G-protein-coupled receptor family, with seven
transmembrane domains. In the skin, H1R is localized in
fibroblasts (Johnson and Johnson, 1990) and endothelial cells
(Baenziger et al., 1981), and both H1R and H2R are expressed
on keratinocytes (Koizumi and Ohkawara, 1999; Kanda and
Watanabe, 2002). Mast cells express functional H2R and
H4R, which upon binding of histamine activate autocrine
feedback mechanisms and thereby act as immunomodulatory
(Lippert et al., 2004). Recently, it was also demonstrated that
histamine regulates T-cell activation and maturation into
TH1/TH2 subtypes (Jutel et al., 2001).
In contrast, PAR2 agonist peptides did not stimulate the
release of tryptase from HPMCs in our experiments (data not
shown). Normally, tryptase is simultaneously released with
histamine from identical mast cell granules. Thus, one
explanation may be that the concentration of tryptase was
under detectable amounts with two different antibody kits
used in our experiments. Alternatively, the stimulated release
of histamine and tryptase may vary among tissues, as shown
for foreskin mast cells and human tonsil mast cells (He et al.,
2005). In colon mast cells, for example, PAR2 agonists were
also capable of stimulating tryptase as well as histamine in
vitro. Therefore, the question whether PAR2 is able to
regulate mast cell function in an autocrine manner via
PAR2 still remains to be further explored.
Together, from our data we propose that PAR2 contributes
to inflammation and hypersensitivity in human skin by
activating intracellular Ca-stores and regulating histamine
release in human skin tissues. The precise mechanism of
neuronal and vascular inflammatory interactions between
PAR receptors and HRs on neurons and endothelial cell is still
unknown, and has to await further clarification (Figure 8).
MATERIALS AND METHODS
Reagents
All chemicals and reagents were obtained from appropriate
commercial sources.
Purified trypsin was purchased from Sigma (Deisenhofen,
Germany). Human b-tryptase was expressed in Pichia pastoris (Niles
et al., 1998). Synthetic agonist peptide for PAR2, as well as control
PAR2 peptide, corresponding to the tethered ligand of human PARs,
were purchased from Ortho-McNeil Pharmaceutical, Spring House,
PA. The sequences of the AP and control (reverse) peptide (RP) for
PAR2 were: SLIGRL-NH2 (AP) and LRGILS-NH2 (RP). The rabbit
monoclonal antibody (B5) to PAR2 was a kind gift from Dr M.
Hollenberg, Calgary, Canada. The following secondary antibody
was used: affinity-purified goat anti-rabbit IgG coupled to FITC was
from Dianova (Hamburg, Germany). Fluo-4-AM was from Molecular
Probes, Eugene, OR. Other materials include: tissue culture reagents
(PAA Laboratories GmbH, Co¨lbe, Germany; Sigma); molecular
biology reagents (Promega, Mannheim, Germany; Eppendorf Hamburg,
Germany; Sigma), and oligonucleotide primers (Invitrogen, Paisley,
Scotland).
Cell culture
The human leukemic mast cell line HMC-1, kindly provided by Dr J.
H. Butterfield (Rochester, MN) was cultured in Iscoves’ medium,
supplemented with 10% fetal calf serum, 10 mM monothioglycerol
and antibiotics (streptomycin and penicillin), at 371C in a humidified
atmosphere containing 5% CO2. The cell line was passaged every
3–4 days.
0 second 26 seconds
356 seconds39 seconds
10 m
Figure 6. Calcium signaling in human primary mast cells following
activation with b-tryptase. HPMCs were cultured and treated as described in
Materials and methods. Tryptase (10 mM) stimulated an increase of [Ca2þ ]I
with a maximum at 30 seconds, as detected by single-cell Ca2þ -mobilization
studies.
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Figure 7. Detection of histamine release from HPMCs after PAR2
stimulation. Histamine release was measured from dermal mast cells after
stimulation with PAR2-AP (10
4
M) and PAR2-RP (10
4
M), respectively. Of
note, PAR2-AP and anti-IgE produced an additive effect on histamine release
from HPMCs. The data represent means 7SEM of values after 15 minutes
treatment with PAR peptides (n¼3 treatments).
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Figure 8. Potential role of mast cells and PAR2 in the neuro-microvascular environment of the skin. (1) Activation of PAR2 localized on human skin mast cells.
(2) PAR2 activation leads to an increase of [Ca
2þ ]I from intracellular calcium stores and subsequent histamine release. (3) Histamine release induces H1R
activation on endothelial cells (Bull et al., 1991) and sensory nerves (Barnes, 1991). (4) Tryptase stimulates neuropeptides release (substance P (SP), calcitonin-
gene related peptide (CGRP)) from sensory nerves via PAR2 (Steinhoff et al., 2000). (5) Tryptase activates endothelial cells expressing PAR2 (Molino et al., 1997).
(6) Stimulation of PAR2 on the cell membrane of mast cells via tryptase. (7) Neuronal substance P induces histamine and tryptase release from skin mast cells
(Ebertz et al., 1987; Steinhoff et al., 2000). (8) Calcitonin-gene related peptide induces vasodilation and hyperemia via interacting with the type 1 calcitonin-
gene related peptide receptor on arterioles (Brain et al., 1985; Holzer, 1998). (9) Substance P induces gap formation, plasma extravasation and granulocyte
infiltration by activating the neurokinin-1 receptor on postcapillary venules (McDonald et al., 1996; Quinlan et al., 1998).
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Mast cells were isolated from human skin tissue and purified by
positive sorting using the monoclonal antibody YB5.B8 against the
Kit receptor (CD 117) and a secondary magnetic microbead-coupled
antibody, as previously described (Gru¨tzkau et al., 2000). Viability of
mast cells was over 95%, as determined by trypan blue staining. Skin
specimens were obtained during surgical breast reductions, with
informed consent.
All use of human skin was conducted according to the
Declaration of Helsinki Principles and was approved by Institutional
Review Boards of both University of Mu¨nster and the Charite
University of Berlin.
RNA isolation and semiquantitative RT-PCR
RNA isolation and RT-PCR analysis were performed as previously
described (Shpacovitch et al., 2002). For PCR amplifications, the
following primer pairs were used: PAR1: forward primer 5
0-
TGTGAACTGATCATGTTTAT-30 and reverse primer 50-TTCGTAAG
ATAAGAGATATGT (708 bp); PAR2: forward primer 5
0-CCATCCA
AGGAACCAATAG-30 and reverse primer 50-CTGAGGCAGGTCATG
AAG-30 (436 bp); PAR3: forward primer 50-CTGATACCTGCCATC
TACCTCC-30 and reverse primer 50-AGAAAACTGTTGCCCACAC-30
(382 bp); PAR4: forward primer 5
0 ATTACTCGGACCCGAGCC-30
and reverse primer 50-TGTAAGGCCCACCCTTCTC-30 (392 bp).
The PCR products for PAR1–4 were amplified from the
same undiluted complementary DNA. The amplification program
was as follows: PAR1 was amplified by the following program: 1
cycle 941C, 5 minutes; followed by 35 cycles of 941C,
1 minute; 531C, 1 minute; 721C, 1 minute; and a final cycle of
721C, 7 minutes. PAR2 was amplified using the following program: 1
cycle 941C, 5 minutes; followed by 35 cycles of 941C, 1 minute;
581C, 1 minute; 721C, 1 minute; and a final cycle of 721C, 7 minutes.
PAR3 was amplified using the following program: 1 cycle 941C,
5 minutes; followed by 35 cycles of 941C, 1 minute; 671C, 1 minute;
721C, 1 minute; and a final cycle of 721C, 7 minutes. PAR4 was
amplified using the following program: 1 cycle 941C, 5 minutes;
followed by 35 cycles of 941C, 1 minute; 631C, 1 minute; 721C,
1 minute; and a final cycle of 721C, 7 minutes. Samples were
resolved on a 2% (w/v) agarose gel and stained by ethidium
bromide. The products were run against a 100 bp DNA ladder
(Enzymes, Muenster, Germany) and were imaged under UV light.
PCR products for PAR2 of the cell line HMC-1 were purified
using a Qiaquick gel extraction kit (Qiagen, Melbourne, Australia)
and DNA sequences were determined by SeqLab GmbH (Go¨ttingen,
Germany).
Flow cytometry
To detect cell surface PAR2, 5 105 cells were incubated in 100 ml
phosphate-buffered saline (PBS)/1% fetal calf serum with rabbit
monoclonal antibody B5 against PAR2 (dilution 1:100 for HMC-1
and 1:25 for primary skin mast cells) for 15 minutes at room
temperature. Goat anti-rabbit IgG antibody served as control. After
washing in PBS/1% fetal calf serum primary antibody was detected
with a FITC-conjugated goat anti-rabbit IgG (HMC-1: 1:100, primary
skin mast cells: 1:50) for 15 minutes at room temperature. Then cells
were washed, resuspended in 500 ml PBS containing 2 mM EDTA and
kept in the dark at room temperature. Cells were analyzed using a
FACScalibur (Becton Dickinson, Heidelberg, Germany), equipped
with CellQuestPro software.
To detect intracellular PAR, cells were fixed with 2% para-
formaldehyde and permeabilized with 0.2% saponin. Cells were
incubated in 100ml 2XPER with rabbit monoclonal antibody B5
against PAR2 (dilution: see above) for 15 minutes at room tempera-
ture. Goat anti-rabbit IgG antibody served as control. After washing
in 2XPER, primary antibody was detected with FITC-conjugated goat
anti-rabbit IgG (dilution: see above) for 15 minutes at room
temperature. Then cells were washed, resuspended in 500 ml PBS
containing 2 mM EDTA and kept in the dark at room temperature
until cytofluorometric analysis.
Double immunofluorescence
Double-immunofluorescence staining was performed with modifica-
tions, as recently described (Steinhoff et al., 1999). Briefly, skin
biopsies were taken from healthy volunteers (n¼ 3) or post-operative
material (n¼ 5) (controls) or lesional and non-lesional skin of patients
suffering from atopic dermatitis (n¼ 6) or urticaria (n¼ 7). Patients did
not receive topical anti-inflammatory agents at sites of inflammation,
systemic medications or UV-irradiation within 2 weeks before
obtaining biopsies. The patients gave informed consent to the biopsies.
Tissues were fixed in Bouin’s fixative for 12 hours, washed, embedded
in OCT compound (Miles, Elhhant, IN), and stored at 801C. Before
use, specimens were sectioned, postfixed with Bouin’s fixative for
20 minutes and washed in PBS, pH 7.4 for 45 minutes. Sections were
incubated with antibodies against PAR2 (PAR2-B5 1:500, PAR2-2C
1:50, and PAR2-N-19 1:200) overnight at 41C. Next day, slides were
washed and incubated with mouse monoclonal antibody against mast
cell tryptase (1:2,000) for 1 hour at room temperature. After thorough
washing in PBS for 3 10 minutes, slides were incubated in a PBS
buffer containing 5% normal goat serum, 1% BSA with a cocktail of
secondary antibodies (goat-anti-rabbit IgG 1:200, sheep-anti-goat IgG
1:200, or donkey-anti-mouse IgG 1:100). After washing in a dark
chamber, slides were mounted in Vectashield (Vector, Burlingame,
CA) and examined using a Leica microscope (Leica DMR, Heidelberg,
Germany). In controls, primary polyclonal antibodies were preincu-
bated 24–48 hours with corresponding peptides (10–100mM) used for
immunization or matched monoclonal Ig control antibodies were
used to elucidate background staining.
Determination of cytoplasmic calcium concentration [Ca2þ ]I
with confocal laser scanning microscopy
Freshly isolated human dermal mast cells that normally grow in
suspension, were cultivated overnight in laminin-coated Petri wells.
Subsequently, more than 70% of these mast cells were adherent to
the laminin-coated surface. The adherence of these cells was an
essential prerequisite for the determination of Ca influx. The increase
of the intracellular Ca2þ concentration in mast cells was visualized
using a confocal laser scanning microscope (Leica, Heidelberg,
Germany) with a water immersion objective XLUMPlanFI
20 0.95w (Olympus). Cells were loaded with 5 mM of Ca2þ -
sensitive, membrane-permeable fluorescent dye Fluo-4-AM (Mole-
cular Probes, Eugene, OR) for 30 minutes at room temperature. After
Fura-4-AM loading, cells were washed 3 times with DMEM without
fetal calf serum and supplemented in 2 ml DMEM. Activating and
reverse peptides for PAR2 (final concentration 10mM) was added to
the cells. The final concentration for the PAR2 agonists trypsin or
tryptase were 0.1 and 10 mM, respectively. Fluo-4-AM was excited by
the 488 nm line of the krypton–argon laser. Fluorescence from green
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channels was collected by photomultiplier tube using filters for
510–560 nm. Images were processed off-line using NIH Image J
software. In each experiment, Ca2þ influx was measured over a
period of 10 minutes.
Histamine release assay
Dermal mast cell suspensions were divided into aliquots, washed
twice with PAG-CM (PIPES albumin glucose buffer containing 3 mM
CaCl2 and 1.5 mM MgCl2), and resuspended at 1 104 cells/ml. Cells
were incubated for 30 minutes at 371C with agonist peptides as well
as control PAR2 peptides (final concentration 10
4
M) before they
were challenged with anti-IgE (dilution 1:20,000). Another portion of
cells was kept in buffer only (PAG-CM) to measure spontaneous
release. Supernatants were stored at 201C until measurement. Total
cellular histamine contents were assessed upon cell lysis with 1%
perchloric acid. Histamine amounts were determined by an
automated fluorescence method (Siraganian, 1975), using an
autoanalyzer (Borgwald Technik, Hamburg, Germany).
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